drugset
Drugs / Succinylated Human Serum Albumin
last change Jun 2006 re-read 3 minutes ago

Succinylated Human Serum Albumin

Protein / enzyme biologic

Developed for
HIV infectious disease
Investigated by
International Antiviral Therapy Evaluation Center · Prothya Biosolutions · University Medical Center Groningen

Trials 1

today NCT00128063 · Ph 1/2
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00128063 Aug 2005 → Jun 2006 HIV infectious disease International Antiviral Therapy Evaluation Center Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Succinylated Human Serum Albumin ClinicalTrials.gov intervention name — accepted as the source's own label NCT00128063 ↗
Action Inhibit “a candidate HIV-1 fusion inhibitor” NCT00128063 ↗
Modality Protein / enzyme biologic “succinylated human serum albumin” NCT00128063 ↗
Route Intravenous “consecutive daily intravenous (i.v.) doses” NCT00128063 ↗